Test Overview
Liquid Chromatography - Tandem Mass Spectrometry (LC-MS/MS)
Monitor therapeutic drug levels; monitor patient compliance; evaluate doxepin toxicity
Therapeutic: 50 - 150 ng/mL (sum of Doxepin and Nordoxepin). Therapeutic ranges are for specimens drawn at trough (ie, immediately before next scheduled dose). Levels may be elevated in non-trough specimens.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Test Details
3 - 5 days
- Adapin
- Sinequan
- Tricyclics, Doxepin
- DOXEPIN AND DEMETHYLDOXEPIN
- DEDOX
- DOX
- Doxepin and Nordoxepin
- DEMETHYLDOXEPIN
- DOXEPIN
- DOXEPIN RESULT
- DOXEPIN & DEMETHYLDOXEPIN LEV
- DOXEPIN + DEMETHYLDOXEPIN LEV
Specimen Requirements
Collect blood in a red top tube immediately before next scheduled dose (minimum 12 hours after last dose); do not use SST tube. Centrifuge, aliquot serum or plasma into plastic vial within 2 hours of collection, and refrigerate.
Additional Information
Doxepin is a tricyclic antidepressant that has been reported to have less cardiotoxicity than the other TADs. Nordoxepine (Desmethyldoxepin), the metabolite of doxepin, is also measured. Test sent to Mayo Clinic Laboratories.